The current position and the future perspectives of cervical cancer screening
RP Bosgraaf, AG Siebers, JA De Hullu… - Expert review of …, 2014 - Taylor & Francis
Cervical screening programs for detecting cancer and precancer have dramatically reduced
the incidence and mortality rates of cervical cancer since the 1960s. The efficacy of the …
the incidence and mortality rates of cervical cancer since the 1960s. The efficacy of the …
Laboratory diagnosis of human papillomavirus infection
H Ikenberg - Human Papillomavirus, 2014 - karger.com
Human papillomaviruses (HPVs) are associated with numerous cutaneous or mucosal
benign and malignant neoplasms. The majority of available data on routine HPV diagnostics …
benign and malignant neoplasms. The majority of available data on routine HPV diagnostics …
Performance of HPV E6/E7 mRNA RT-qPCR for screening and diagnosis of cervical cancer with ThinPrep® Pap test samples
J Munkhdelger, G Kim, H Wang, D Lee, S Kim… - Experimental and …, 2014 - Elsevier
Recent research has shown that oncogenic human papillomavirus (HPV) DNA, which is
currently used in the screening and diagnosis of cervical cancer, can be detected not only in …
currently used in the screening and diagnosis of cervical cancer, can be detected not only in …
Assessment of HPV-mRNA test to predict recurrent disease in patients previously treated for CIN 2/3
Background The use of HPV-mRNA test in the follow-up after LEEP is still matter of debate,
with regard to its capacity of prediction relapse. Objective The aim of the present study is to …
with regard to its capacity of prediction relapse. Objective The aim of the present study is to …
Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix
J Munkhdelger, Y Choi, D Lee, S Kim, G Kim… - … and Infectious Disease, 2014 - Elsevier
This study aims to evaluate the clinical performance of the NucliSENS EasyQ assay and
compare it with HPV DNA genotyping for the detection of high-grade squamous …
compare it with HPV DNA genotyping for the detection of high-grade squamous …
[PDF][PDF] Amplification of TERT and TERC genes in cervical intraepithelial neoplasia and cervical cancer
J Visnovsky, E Kudela, A Farkasova, T Balharek… - Neuroendocrinol …, 2014 - nel.edu
OBJECTIVES: Telomerase is activated in various stages of oncogenesis. For cervical
cancer, telomerase is already active in precancerous lesions. In our study we focused on the …
cancer, telomerase is already active in precancerous lesions. In our study we focused on the …
Vaccination against HPV-associated neoplasias
G Gross, N Becker, NH Brockmeyer… - Geburtshilfe und …, 2014 - thieme-connect.com
2 Methods The present guidelines are an update of the first version of the S3 guideline on
vaccination against neoplasias published in 2009 (short version)[4]. The core guideline …
vaccination against neoplasias published in 2009 (short version)[4]. The core guideline …
[PDF][PDF] The diagnostic accuracy of E6 & 7 mRNA detection as a primary screening test for the detection of severe cervical lesions
V Stathopoulou, G Koliopoulos, D Zygouris… - Journal of BU ON, 2014 - jbuon.com
Purpose: This prospective accuracy study aimed to assess the diagnostic accuracy of
nucleic acid sequence amplification (NASBA) and flow cytometry for E6/7 human …
nucleic acid sequence amplification (NASBA) and flow cytometry for E6/7 human …